Sau San Tong Holdings Limited (8200) AI Stock Analysis

• Market Cap: HK$50.46M
• Dividend Yield: N/A
• Average Volume (3M): 94.18K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.56
• Revenue Growth: -23.13%
• EPS Growth: -263.65%
• Country: HK
• Employees: 198
• Sector: Real Estate
• Sector Strength: 46
• Industry: Household & Personal Products
• EPS (TTM): -0.20
• Shares Outstanding: 78,842,030
• 10 Day Avg. Volume: 143,617
• 30 Day Avg. Volume: 94,184
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): N/A
• P/FCF Ratio: N/A
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: HK$0.50
• Price Target Upside: -27.54% Downside
• Rating Consensus: Hold
• Number of Analyst Covering: 1

• Rating: 47 Neutral
• Price Target: HK$0.50 ▼(-27.54% Downside)

The overall stock score is primarily impacted by significant financial challenges, including declining revenues and negative profitability. Technical analysis provides a neutral outlook, while valuation metrics are unfavorable due to a negative P/E ratio and lack of dividend yield.

Sau San Tong Holdings Limited Business Overview & Revenue Model

Company Description

Sau San Tong Holdings Limited (8200) is a Hong Kong-based company primarily engaged in the trading and distribution of traditional Chinese medicine (TCM) products, as well as health supplements. The company operates within the broader healthcare and wellness sector, focusing on enhancing the well-being of its customers through high-quality herbal products and remedies. Sau San Tong Holdings also emphasizes the importance of research and development in traditional medicine, aiming to innovate while preserving the rich heritage of TCM.

How the Company Makes Money

Sau San Tong Holdings Limited generates revenue through multiple channels within the traditional Chinese medicine market. The primary revenue stream comes from the sale of TCM products, which includes a wide range of herbal medicines, dietary supplements, and related health products. The company also engages in direct sales and distribution through retail outlets and online platforms, expanding its market reach. Additionally, Sau San Tong may benefit from partnerships with healthcare professionals and wellness centers that promote its products. Factors contributing to its earnings include the growing consumer interest in alternative medicine, increasing health consciousness, and the company's ability to maintain product quality and compliance with health regulations.

Sau San Tong Holdings Limited Financial Statement Overview

Summary

Sau San Tong Holdings Limited faces significant financial challenges, with declining revenues and persistent profitability issues, as evidenced by negative profit margins and returns on equity. The balance sheet shows low leverage, but negative cash flow trends indicate potential liquidity concerns.

Income Statement

Sau San Tong Holdings Limited has experienced declining revenue over recent years, with a negative revenue growth rate of -2.37% in the latest year. The company has consistently reported negative net profit margins, indicating ongoing profitability challenges. Gross profit margins have also decreased, reflecting potential issues in cost management or pricing strategy. The EBIT and EBITDA margins are negative, highlighting operational inefficiencies.

Balance Sheet

The company's balance sheet shows a low debt-to-equity ratio of 0.0186, suggesting conservative leverage and low financial risk. However, the return on equity is negative, indicating that the company is not generating sufficient returns on shareholders' equity. The equity ratio is relatively stable, reflecting a solid equity base compared to total assets.

Cash Flow

Cash flow analysis reveals significant challenges, with negative operating and free cash flows in the latest year. The free cash flow growth rate is highly negative, indicating deteriorating cash generation capabilities. The operating cash flow to net income ratio is negative, suggesting that the company is struggling to convert its earnings into cash.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	860.43M	840.02M	1.09B	1.23B	1.56B	1.79B
Gross Profit	68.05M	49.60M	104.57M	99.12M	137.17M	144.49M
EBITDA	-35.32M	-31.15M	6.59M	9.90M	41.94M	21.82M
Net Income	-37.94M	-51.98M	-14.30M	-13.93M	8.95M	-26.42M
Balance Sheet
Total Assets	781.99M	770.90M	843.36M	901.34M	961.20M	982.77M
Cash, Cash Equivalents and Short-Term Investments	420.18M	419.43M	492.91M	523.28M	529.27M	537.96M
Total Debt	5.89M	13.26M	9.53M	5.44M	6.59M	11.53M
Total Liabilities	72.91M	81.28M	87.35M	125.64M	141.19M	174.49M
Stockholders Equity	735.25M	714.66M	770.03M	789.65M	807.44M	800.28M
Cash Flow
Free Cash Flow	8.33M	-26.17M	-11.23M	23.10M	-18.13M	44.62M
Operating Cash Flow	14.02M	-25.05M	-5.55M	41.13M	-5.70M	47.28M
Investing Cash Flow	152.49M	378.00K	-5.64M	-17.84M	-12.05M	22.05M
Financing Cash Flow	-22.38M	-21.27M	-9.36M	-29.84M	-20.74M	-13.66M

Sau San Tong Holdings Limited Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 0.69
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:8200, the sentiment is Positive. The current price of 0.69 is above the 20-day moving average (MA) of 0.54, above the 50-day MA of 0.50, and above the 200-day MA of 0.47, indicating a bullish trend. The MACD of 0.04 indicates Negative momentum. The RSI at 66.38 is Neutral, neither overbought nor oversold. The STOCH value of 73.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:8200.

Sau San Tong Holdings Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
2023	65 Neutral	HK$422.95M	7.43	12.01%	―	25.55%	14.47%
3332	61 Neutral	HK$648.05M	10.10	8.96%	―	30.72%	-35.61%
Sector *	53 Neutral	$1.24B	2.72	-2.60%	5.65%	-2.15%	-149.23%
1259	51 Neutral	$74.91M	―	-8.28%	―	-1.73%	-42.35%
8200	47 Neutral	HK$50.46M	―	-7.00%	―	-23.13%	-263.65%
8281	44 Neutral	HK$102.00M	31.88	1.13%	4.10%	-12.00%	-57.89%
0157	41 Neutral	$1.10B	―	-12.38%	―	39.29%	-71.82%